Glaxosmithkline Plc (GSK)

$38.53 0.06 (0.16%)

4:27 EST GSK Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 95.55B

PE Ratio 92.62

EPS 0.416

Volume (Avg. Vol.) 400

Day's Range 38.47 - 38.47

52-Week Range 31.43 - 48.25

Dividend & Yield 2.14 (5.55%)

GSK Stock Predictions, Articles, and Glaxosmithkline Plc News

From InvestorPlace
From the Web

8 Dental Stocks If You Want to Clean Up

By Josh Enomoto, InvestorPlace Contributor Dec 31, 2020

As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.

The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure

By Tezcan Gecgil, InvestorPlace Contributor Dec 8, 2020

Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.

GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal

By Sarah Smith, InvestorPlace Web Content Producer Sep 18, 2020

GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.

7 Coronavirus Vaccine Stocks to Watch as Approval Nears

By Thomas Niel Sep 14, 2020

Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)

5 Hot Stocks to Buy Still Profiting From Social Distancing

By Tezcan Gecgil, InvestorPlace Contributor Sep 11, 2020

Although broader markets may continue to be volatilie in the rest of the year, these five hot stocks to buy should be on your shopping list.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline

By David Moadel, InvestorPlace Contributor May 8, 2020

Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.

10 S&P 500 Stocks to Buy Increasing Their Dividends in 2020

By Will Ashworth, InvestorPlace Contributor Apr 13, 2020

A number of S&P 500 companies have already increased their 2020 dividends by 10% or more. Here are 10 stocks to buy among this group.

Amarin Has the Makings for a Gamechanging Product

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Dec 13, 2019

Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.

4 Stocks to Sell and 6 Stocks to Buy on Vaping Fears

By James Brumley, InvestorPlace Feature Writer Sep 26, 2019

Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.

5 Dividend Stocks to Buy From Across the Globe

By Aaron Levitt, InvestorPlace Contributor Jul 3, 2019

With international dividend stocks, valuations are generally better and yields are bigger. Here are five stocks that stand out.

10 Risky (But Rewarding) Small-Cap Stocks to Buy Now

By James Brumley, InvestorPlace Feature Writer Apr 5, 2019

These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.

9 Blue-Chip Stocks That Will Lose You Money

By James Brumley, InvestorPlace Feature Writer Mar 5, 2019

Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.

3 Life Sciences Stocks to Invest In

By Chris Lau, InvestorPlace Contributor Mar 1, 2019

Generic drug companies are on discount for investors who want to buy life sciences stocks. Why, and when will this sector recover?

3 Biopharma Stocks to Buy for Their Robust Dividend Yields

By Tezcan Gecgil, InvestorPlace Contributor Jan 3, 2019

These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.

GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture

By William White, InvestorPlace Writer Dec 19, 2018

GlaxoSmithKline (GSK) stock is up today on news of a new joint venture with Pfizer (PFE) for a consumer healthcare business.

3 Big Stock Charts for Tuesday: Morgan Stanley, Ross Stores and Dominion Energy

By James Brumley, InvestorPlace Feature Writer Dec 4, 2018

The stock charts of ROST, D and MS are shaping up as the top trading prospects as December's action gets going.

TSRO, GSK: Tesaro Stock Skyrockets on GlaxoSmithKline Deal

By William White, InvestorPlace Writer Dec 3, 2018

Tesaro stock was flying high on Monday with news that GlaxoSmithKline (GSK) is planning to acquire it in a deal worth $5.10 billion.

6 of the Best Dividend Stocks Outside the U.S.

By Vince Martin, InvestorPlace Contributor Oct 3, 2018

If you're looking for the best dividend stocks with high yields and solid growth prospects, don't limit yourself -- look overseas.

7 Healthcare Stocks That Are Coming to Life

By Anthony Mirhaydari, InvestorPlace Market Strategist Jul 23, 2018

These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.

Navellier Ratings

Total Grade

Strong Sell

Glaxosmithkline Plc (GSK)

GSK Stock Predictions, Articles, and Glaxosmithkline Plc News

Navellier Ratings

Total Grade

Subscriber Sign in